Sec. 2004. REAUTHORIZATION; REPORTING REQUIREMENTS

160 words·~1 min read·/statute-compilations/comps-17191/sec-2004

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

## SEC. 2004 REAUTHORIZATION; REPORTING REQUIREMENTS ###

(a)Performance Reports Section 738A(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-1(a)) is amended— ####

(1)by striking “fiscal year 2018” each place it appears and inserting “fiscal year 2023”; ####

(2)by striking “Medical Device User Fee Amendments of 2017” each place it appears and inserting “Medical Device User Fee Amendments of 2022”; ####

(3)in paragraph (1)— #####

(A)in subparagraph (A), by redesignating the second clause

(iv)(relating to analysis) as clause (v); and #####

(B)in subparagraph (A)(iv), by striking “fiscal year 2020” and inserting “fiscal year 2023”; and ####

(4)in paragraph (4), by striking “2018 through 2022” and inserting “2023 through 2027”. ###

(b)Reauthorization Section 738A(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-1(b)) is amended— ####

(1)in paragraph (1), by striking “2022” and inserting “2027”; and ####

(2)in paragraph (5), by striking “2022” and inserting “2027”.

Connectionstraces to 1

Traces to 1 document

U.S. Code

Citation graph

cites case law

Sec. 2004

REAUTHORIZATION; REPORTING REQUIREMENTS

Cites 1Cited by 0 across 0 sources